4-Fluoroiodobenzene → HCID 178519322, compound

HRID 82052

Reaction equation

HRID 82052 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5](I)=[CH:4][CH:3]=1.[Na].[F-].C([N+](CCCC)(CCCC)CCCC)CCC.C(OC([N:35]1[CH2:40][CH2:39][N:38]([C:41]([C:43]2[C:44]3[C:58]([CH:59]=[CH2:60])=[N:57][N:56](C4CCCCO4)[C:45]=3[N:46]=[C:47]([C:49]3[CH:54]=[CH:53][C:52]([OH:55])=[CH:51][CH:50]=3)[CH:48]=2)=[O:42])[CH2:37][CH2:36]1)=O)(C)(C)C>CN(C=O)C.C(OCC)(=O)C.C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[F:1][C:2]1[CH:7]=[CH:6][C:5](/[CH:60]=[CH:59]/[C:58]2[C:44]3[C:45](=[N:46][C:47]([C:49]4[CH:54]=[CH:53][C:52]([OH:55])=[CH:51][CH:50]=4)=[CH:48][C:43]=3[C:41]([N:38]3[CH2:37][CH2:36][NH:35][CH2:40][CH2:39]3)=[O:42])[NH:56][N:57]=2)=[CH:4][CH:3]=1

Participants

8

Conditions

Temperature
80 °C

Procedure

0.25 mmol of 1-fluoro-4-iodo-benzene were weighted into a reaction tube. 2.5 mmol sodium hadrogencarbonate was added as solid, followed by 0.25 mmol tetrabutylammonium fluoride in 0.5 ml DMF and 0.1 mmol of 4-[6-(4-hydroxy-phenyl)-1-(tetrahydro-pyran-2-yl)-3-vinyl-1H-pyrazolo[3,4-b]pyridine-4-carbonyl]-piperazine-1-carboxylic acid tert-butyl ester in 1 ml DMF. The tube was purged with Argon. 0.01 mmol palladium(II) acetate in 0.25 mmol DMF was added, the tube was closed with a screw cap and stirred for 8 h at 80° C. New palladium(II) acetate (0.01 mmol) was added and heating continued for 1 h at 100° C. The reaction mixture was diluted with 20 ml ethyl acetate and washed with 20 ml water, dried and evaporated. The residue was dissolved in 5 ml THF and 1 ml methanol and shaken with 100 mg silica-bound propane thiol scavenger for 4 h at RT. The mixture was filtered, the filter washed with THF, the filtrate evaporated and the residue submitted to SFC purification. The purified product was dissolved in 3 ml methanol and 0.5 ml 4N HCl in dioxane. The mixture was stirred for 30 min at 65° C. The cooled solution was diluted slowly with ml diethyl ether to precipitate the product, which was filtered off, washed with 1 ml diethyl ether, and dried in vacuo to afford [3-[(E)-2-(4-Fluoro-phenyl)-vinyl]-6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-piperazin-1-yl-methanone (18 mg, 37%).

Workup

  1. customThe tube was purged with Argon
  2. customthe tube was closed with a screw
  3. customcap
  4. temperatureheating
  5. waitcontinued for 1 h at 100° C
  6. washwashed with 20 ml water
  7. customdried
  8. customevaporated
  9. dissolutionThe residue was dissolved in 5 ml THF
  10. stirring1 ml methanol and shaken with 100 mg silica-bound propane thiol scavenger for 4 h at RT
  11. filtrationThe mixture was filtered
  12. washthe filter washed with THF
  13. customthe filtrate evaporated
  14. customthe residue submitted to SFC purification
  15. dissolutionThe purified product was dissolved in 3 ml methanol
  16. stirringThe mixture was stirred for 30 min at 65° C
  17. additionThe cooled solution was diluted slowly with ml diethyl ether
  18. customto precipitate the product, which
  19. filtrationwas filtered off
  20. washwashed with 1 ml diethyl ether
  21. customdried in vacuo

Sources & evidence

ORD record
ord-dd210c383e2b44b0a7bbccf413c07fab
Source dataset
uspto-grants-2014_09
Patent number
US08846712B2

Linked notes

Loading…